B-cell Maturation Antigen (BCMA) is a protein expressed on the surface of mature B-cells and plasma cells. In multiple myeloma, a type of blood cancer that affects plasma cells, BCMA is often overexpressed, making it an attractive target for novel therapies. The discovery of BCMA's role in the pathogenesis of multiple myeloma has led to the development of various targeted therapies, o... https://livepositively.com/advancements-in-b-cell-maturation-antigen-bcma-targeted-therapies-for-multiple-myeloma-treatment/